Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 19/20 | 0.58 |
| ▸ | PDE4A | P27815 | 17/20 | 0.58 |
| ▸ | PDE4B | Q07343 | 17/20 | 0.58 |
| ▸ | PDE4C | Q08493 | 17/20 | 0.58 |
| ▸ | GFER | P55789 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8324467 | 0.99 | PDE4D (0.57) | PDE4DPDE4APDE4BPDE4CGFER | |
| SCHEMBL6921519 | 0.98 | PDE4D (0.58) | PDE4DPDE4APDE4BPDE4CGFER | |
| SCHEMBL6919528 | 0.82 | MAPT (0.48) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL8320511 | 0.82 | MAPT (0.48) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL8325303 | 0.79 | PDE4D (0.64) | PDE4DPDE4APDE4BPDE4CGFER | |
| SCHEMBL6922067 | 0.78 | USP2 (0.43) | GFER | |
| SCHEMBL8321734 | 0.78 | PDE4D (0.55) | PDE4DPDE4APDE4BPDE4CGFER | |
| SCHEMBL8319816 | 0.78 | PDE4D (0.63) | PDE4DPDE4APDE4BPDE4CGFER | |
| SCHEMBL5022663 | 0.78 | PDE4D (0.60) | PDE4DPDE4APDE4BPDE4CGFER | |
| SCHEMBL6918015 | 0.77 | GFER (0.50) | GFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004069831-A1 | TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-08-19 | — | — | WO | claimed |
| WO-2004069831-A1 | TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-08-19 | — | — | WO | disclosed |